Evidence supporting the use of: Vitamin C (not specified)
For the health condition: Lead Poisoning

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin C (ascorbic acid) has some scientific evidence supporting its use in the management of lead poisoning, although the strength of the evidence is moderate and primarily based on animal studies and limited human data. Vitamin C is thought to reduce lead absorption in the gastrointestinal tract and enhance urinary excretion of lead by acting as a chelating agent and antioxidant. Some studies in animals have demonstrated that vitamin C supplementation can decrease blood and tissue lead levels and ameliorate lead-induced oxidative damage.

In humans, observational studies have suggested that higher vitamin C intake or blood levels are associated with lower blood lead concentrations. For example, a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey (NHANES III) found an inverse relationship between serum vitamin C levels and blood lead levels in adults. Additionally, small clinical trials have shown that vitamin C supplementation can reduce blood lead levels in populations with chronic low-level lead exposure.

However, vitamin C is not considered a primary therapy for lead poisoning, where chelation agents (such as EDTA or DMSA) are standard. Vitamin C may have a supportive role, particularly in mild cases or as an adjunct to chelation therapy, but more rigorous clinical trials are needed to establish its efficacy and optimal dosing. Current evidence supports its use as a potential supplement rather than a replacement for established treatments.

More about Vitamin C (not specified)
More about Lead Poisoning

Products containing Vitamin C (not specified)

We currently have no products on Vitabase that contain this ingredient.